Cargando…
A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa
Since the eradication of smallpox and the subsequent discontinuation of the worldwide smallpox vaccination program, other Orthopoxviruses beside Variola virus have been increasingly representing a risk to human health. To investigate the extent of natural contact with Orthopoxviruses and possible de...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691630/ https://www.ncbi.nlm.nih.gov/pubmed/28961172 http://dx.doi.org/10.3390/v9100278 |
_version_ | 1783279825572593664 |
---|---|
author | Leendertz, Siv Aina J. Stern, Daniel Theophil, Dennis Anoh, Etile Mossoun, Arsène Schubert, Grit Wiersma, Lidewij Akoua-Koffi, Chantal Couacy-Hymann, Emmanuel Muyembe-Tamfum, Jean-Jacques Karhemere, Stomy Pauly, Maude Schrick, Livia Leendertz, Fabian H. Nitsche, Andreas |
author_facet | Leendertz, Siv Aina J. Stern, Daniel Theophil, Dennis Anoh, Etile Mossoun, Arsène Schubert, Grit Wiersma, Lidewij Akoua-Koffi, Chantal Couacy-Hymann, Emmanuel Muyembe-Tamfum, Jean-Jacques Karhemere, Stomy Pauly, Maude Schrick, Livia Leendertz, Fabian H. Nitsche, Andreas |
author_sort | Leendertz, Siv Aina J. |
collection | PubMed |
description | Since the eradication of smallpox and the subsequent discontinuation of the worldwide smallpox vaccination program, other Orthopoxviruses beside Variola virus have been increasingly representing a risk to human health. To investigate the extent of natural contact with Orthopoxviruses and possible demographic risk factors for such an exposure, we performed a cross-sectional serosurvey of anti-Orthopoxvirus IgG antibodies in West and Central Africa. To this end, people living in forest regions in Côte d’Ivoire (CIV, n = 737) and the Democratic Republic of the Congo (COD, n = 267) were assigned into groups according to their likely smallpox vaccination status. The overall prevalence of anti-Orthopoxvirus antibodies was 51% in CIV and 60% in COD. High rates of seropositivity among the vaccinated part of the population (80% in CIV; 96% COD) indicated a long-lasting post vaccination immune response. In non-vaccinated participants, seroprevalences of 19% (CIV) and 26% (COD) indicated regular contact with Orthopoxviruses. Multivariate logistic regression revealed that the antibody level in the vaccinated part of the population was higher in COD than in CIV, increased with age and was slightly higher in females than males. In the unvaccinated part of the population none of these factors influenced antibody level significantly. In conclusion, our results confirm expectedly high anti-Orthopoxvirus seroprevalences in previously smallpox-vaccinated people living in CIV and the COD but more unexpectedly imply regular contact with Orthopoxviruses both in Western and Central Africa, even in the absence of recognized outbreaks. |
format | Online Article Text |
id | pubmed-5691630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56916302017-11-22 A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa Leendertz, Siv Aina J. Stern, Daniel Theophil, Dennis Anoh, Etile Mossoun, Arsène Schubert, Grit Wiersma, Lidewij Akoua-Koffi, Chantal Couacy-Hymann, Emmanuel Muyembe-Tamfum, Jean-Jacques Karhemere, Stomy Pauly, Maude Schrick, Livia Leendertz, Fabian H. Nitsche, Andreas Viruses Article Since the eradication of smallpox and the subsequent discontinuation of the worldwide smallpox vaccination program, other Orthopoxviruses beside Variola virus have been increasingly representing a risk to human health. To investigate the extent of natural contact with Orthopoxviruses and possible demographic risk factors for such an exposure, we performed a cross-sectional serosurvey of anti-Orthopoxvirus IgG antibodies in West and Central Africa. To this end, people living in forest regions in Côte d’Ivoire (CIV, n = 737) and the Democratic Republic of the Congo (COD, n = 267) were assigned into groups according to their likely smallpox vaccination status. The overall prevalence of anti-Orthopoxvirus antibodies was 51% in CIV and 60% in COD. High rates of seropositivity among the vaccinated part of the population (80% in CIV; 96% COD) indicated a long-lasting post vaccination immune response. In non-vaccinated participants, seroprevalences of 19% (CIV) and 26% (COD) indicated regular contact with Orthopoxviruses. Multivariate logistic regression revealed that the antibody level in the vaccinated part of the population was higher in COD than in CIV, increased with age and was slightly higher in females than males. In the unvaccinated part of the population none of these factors influenced antibody level significantly. In conclusion, our results confirm expectedly high anti-Orthopoxvirus seroprevalences in previously smallpox-vaccinated people living in CIV and the COD but more unexpectedly imply regular contact with Orthopoxviruses both in Western and Central Africa, even in the absence of recognized outbreaks. MDPI 2017-09-29 /pmc/articles/PMC5691630/ /pubmed/28961172 http://dx.doi.org/10.3390/v9100278 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Leendertz, Siv Aina J. Stern, Daniel Theophil, Dennis Anoh, Etile Mossoun, Arsène Schubert, Grit Wiersma, Lidewij Akoua-Koffi, Chantal Couacy-Hymann, Emmanuel Muyembe-Tamfum, Jean-Jacques Karhemere, Stomy Pauly, Maude Schrick, Livia Leendertz, Fabian H. Nitsche, Andreas A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa |
title | A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa |
title_full | A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa |
title_fullStr | A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa |
title_full_unstemmed | A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa |
title_short | A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa |
title_sort | cross-sectional serosurvey of anti-orthopoxvirus antibodies in central and western africa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691630/ https://www.ncbi.nlm.nih.gov/pubmed/28961172 http://dx.doi.org/10.3390/v9100278 |
work_keys_str_mv | AT leendertzsivainaj acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT sterndaniel acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT theophildennis acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT anohetile acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT mossounarsene acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT schubertgrit acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT wiersmalidewij acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT akouakoffichantal acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT couacyhymannemmanuel acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT muyembetamfumjeanjacques acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT karhemerestomy acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT paulymaude acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT schricklivia acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT leendertzfabianh acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT nitscheandreas acrosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT leendertzsivainaj crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT sterndaniel crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT theophildennis crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT anohetile crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT mossounarsene crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT schubertgrit crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT wiersmalidewij crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT akouakoffichantal crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT couacyhymannemmanuel crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT muyembetamfumjeanjacques crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT karhemerestomy crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT paulymaude crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT schricklivia crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT leendertzfabianh crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica AT nitscheandreas crosssectionalserosurveyofantiorthopoxvirusantibodiesincentralandwesternafrica |